End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8925 USD | -2.25% | +6.25% | -96.71% |
04-19 | Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product | MT |
04-19 | Top Premarket Decliners | MT |
Evolution of the average Target Price on Sunshine Biopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sunshine Biopharma, Inc.
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- SBFM Stock
- Consensus Sunshine Biopharma, Inc.